HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness

Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis

(2017) Pietro Mazzuca et al.   JOURNAL OF VIROLOGY

U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis

(2017) Francesca Caccuri et al.   Oncotarget

A lymphomagenic role for HIV beyond immune suppression?

(2016) R. Dolcetti et al.   BLOOD

Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice

(2016) Virginia A. Carroll et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17

(2016) Francesca Caccuri et al.   Scientific Reports

Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective study

(2015) Alexandra Gomez et al.   BREAST CANCER RESEARCH AND TREATMENT

Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis

(2015) Riccardo Dolcetti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells

(2015) Sangmin Kim et al.   TUMOR BIOLOGY

Oncogenic potential of hepatitis B virus encoded proteins

(2015) Marc Ringelhan et al.   Current Opinion in Virology

Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17

(2015) Daniele Basta et al.   Pathogens and Disease

HIV-1 Matrix Protein p17 Promotes Lymphangiogenesis and Activates the Endothelin-1/Endothelin B Receptor Axis

(2014) Francesca Caccuri et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Human Viral Oncogenesis: A Cancer Hallmarks Analysis

(2014) Enrique A. Mesri et al.   Cell Host & Microbe

Simian Immunodeficiency Virus and Human Immunodeficiency Virus Type 1 Matrix Proteins Specify Different Capabilities To Modulate B Cell Growth

(2014) F. Caccuri et al.   JOURNAL OF VIROLOGY

Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study

(2014) Maria Luisa Iaria et al.   VACCINE

Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003

(2013) Pragna Patel et al.   ANNALS OF INTERNAL MEDICINE

Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa

(2013) Herbert Cubasch et al.   BREAST CANCER RESEARCH AND TREATMENT

HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation

(2012) C. Giagulli et al.   BLOOD

Breast cancer among HIV infected individuals from the ONCOVIH study, in France: Therapeutic implications

(2012) Jean-Philippe Spano et al.   EUROPEAN JOURNAL OF CANCER

HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2

(2012) F. Caccuri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Directly Infected Resting CD4+T Cells Can Produce HIV Gag without Spreading Infection in a Model of HIV Latency

(2012) Matthew J. Pace et al.   PLoS Pathogens

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer Burden in the HIV-Infected Population in the United States

(2011) Meredith S. Shiels et al.   JNCI-Journal of the National Cancer Institute

Is there an association between human immunodeficiency virus infection and breast cancer?

(2011) Hamid Salim Shaaban et al.   MEDICAL ONCOLOGY

Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells

(2011) Cinzia Giagulli et al.   PLoS One

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

(2010) Christophe Ginestier et al.   JOURNAL OF CLINICAL INVESTIGATION

HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS

(2010) Simona Fiorentini et al.   PHARMACOLOGY & THERAPEUTICS

Non-0002030-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities

(2009) Eric A Engels   AIDS

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study

(2008) Nancy Crum-Cianflone et al.   AIDS

HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1

(2008) Elena Marini et al.   CELLULAR MICROBIOLOGY

Cancer risk in people infected with human immunodeficiency virus in the United States

(2008) Eric A. Engels et al.   INTERNATIONAL JOURNAL OF CANCER

Epstein-Barr Virus-Encoded LMP1 Regulates Epithelial Cell Motility and Invasion via the ERK-MAPK Pathway

(2008) C. W. Dawson et al.   JOURNAL OF VIROLOGY

HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype

(2008) S. Fiorentini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8

(2008) K. Wu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Evolving spectrum and incidence of non-AIDS-defining malignancies

(2008) Liron Pantanowitz et al.   Current Opinion in HIV and AIDS